Rebecca F Rogers

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Dna Damage Response

Endoplasmic Reticulum Stress

Idiopathic Pulmonary Fibrosis

Top Venues

Cancer research

Nature communications

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa Izquierdo, Diana M Carvalho, Alan Mackay, Sara Temelso, Jessica K R Boult, Giulia Pericoli, Elisabet Fernandez, Molina Das, Valeria Molinari, Yura Grabovska, Rebecca F Rogers, Maria Antonietta Ajmone-Cat, Paula Z Proszek, Mark Stubbs, Sarita Depani, Patricia O'Hare, Lu Yu, Georgia Roumelioti, Jyoti S Choudhary, Matthew Clarke, Amy R Fairchild, Thomas S Jacques, Richard G Grundy, Lisa Howell, Susan Picton, Jenny Adamski, Shaun Wilson, Juliet C Gray, Bassel Zebian, Lynley V Marshall, Fernando Carceller, Jacques Grill, Maria Vinci, Simon P Robinson, Michael Hubank, Darren R Hargrave, Chris Jones
DIPG harbour alterations targetable by MEK inhibitors, with acquired resistance mechanisms overcome by combinatorial inhibition. Cancer discovery (2021)
Rebecca F Rogers, Michael I Walton, Daniel L Cherry, Ian Collins, Paul Andrew Clarke, Michelle D Garrett, Paul Workman
CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells. Cancer research 80 (8) (2020)
Alison E John, Rebecca H Graves, K Tao Pun, Giovanni Vitulli, Ellen J Forty, Paul F Mercer, Josie L Morrell, John W Barrett, Rebecca F Rogers, Maryam Hafeji, Lloyd I Bibby, Elaine Gower, Valerie S Morrison, Yim Man, James A Roper, Jeni C Luckett, Lee A Borthwick, Ben S Barksby, Rachel A Burgoyne, Rory Barnes, Joelle Le, David J Flint, Susan Pyne, Anthony Habgood, Louise A Organ, Chitra Joseph, Rochelle C Edwards-Pritchard, Toby M Maher, Andrew J Fisher, Natasja Stæhr Gudmann, Diana J Leeming, Rachel Clare Chambers, Pauline T Lukey, Richard P Marshall, Simon J F Macdonald, R Gisli Jenkins, Robert J Slack
Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis. Nature communications 11 (1) (2020)